BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15196239)

  • 1. Mast cells at the host-pathogen interface: host-protection versus immune evasion in leishmaniasis.
    Saha B; Tonkal AM; Croft S; Roy S
    Clin Exp Immunol; 2004 Jul; 137(1):19-23. PubMed ID: 15196239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
    Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S
    Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani.
    Reiner NE
    J Immunol; 1987 Mar; 138(6):1919-25. PubMed ID: 3493291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage-T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania-infected macrophages and its implication in the suppression of cell-mediated immunity.
    Saha B; Das G; Vohra H; Ganguly NK; Mishra GC
    Eur J Immunol; 1995 Sep; 25(9):2492-8. PubMed ID: 7589116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
    Narayan S; Bimal S; Singh SK; Gupta AK; Singh VP; Sinha PK; Das P
    Exp Parasitol; 2009 Jan; 121(1):69-75. PubMed ID: 18948098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of protective T cells from BALB/cJ mice chronically infected with Leishmania donovani.
    Holaday B; Sadick MD; Pearson RD
    J Immunol; 1988 Sep; 141(6):2132-7. PubMed ID: 3262649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cell degranulation contributes to susceptibility to Leishmania major.
    Romão PR; Da Costa Santiago H; Ramos CD; De Oliveira CF; Monteiro MC; De Queiroz Cunha F; Vieira LQ
    Parasite Immunol; 2009 Mar; 31(3):140-6. PubMed ID: 19222785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of mannose receptor during experimental leishmaniasis.
    Akilov OE; Kasuboski RE; Carter CR; McDowell MA
    J Leukoc Biol; 2007 May; 81(5):1188-96. PubMed ID: 17261547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cells are activated by Leishmania mexicana LPG and regulate the disease outcome depending on the genetic background of the host.
    Villaseñor-Cardoso MI; Salaiza N; Delgado J; Gutiérrez-Kobeh L; Pérez-Torres A; Becker I
    Parasite Immunol; 2008 Aug; 30(8):425-34. PubMed ID: 18507782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection.
    Melby PC; Tabares A; Restrepo BI; Cardona AE; McGuff HS; Teale JM
    Exp Parasitol; 2001 Sep; 99(1):17-25. PubMed ID: 11708830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of Leishmania donovani infection levels by selective impairment of macrophage signal transduction.
    Moore KJ; Labrecque S; Matlashewski G
    J Immunol; 1993 May; 150(10):4457-65. PubMed ID: 8482844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the host response to Leishmania mexicana.
    Pérez H
    Ciba Found Symp; 1983; 99():157-73. PubMed ID: 6227462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional heterogeneity of macrophage precursor cells from spleen of Leishmania donovani-infected and untreated mice.
    Hockertz S; Baccarini M; Lohmann-Matthes ML
    J Immunol; 1989 Apr; 142(7):2489-94. PubMed ID: 2926141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of variables associated with promotion of resistance and its abrogation in T cell-reconstituted nude mice infected with Leishmania major.
    Moll H; Mitchell GF
    J Parasitol; 1988 Dec; 74(6):993-8. PubMed ID: 3264023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania infantum: soluble proteins released by the parasite exert differential effects on host immune response.
    Rosa R; Rodrigues OR; Marques C; Santos-Gomes GM
    Exp Parasitol; 2005 Feb; 109(2):106-14. PubMed ID: 15687017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of lymphokines in the control of multiplication and dispersion of Leishmania donovani within liver macrophages of resistant and susceptible mice.
    Olivier M; Proulx C; Tanner CE
    J Parasitol; 1989 Oct; 75(5):720-7. PubMed ID: 2529362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological factors governing resistance and susceptibility of mice to Leishmania major infection.
    Aguilar-Torrentera F; Carlier Y
    Rev Latinoam Microbiol; 2001; 43(3):135-42. PubMed ID: 17061500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis.
    Engwerda CR; Ato M; Kaye PM
    Trends Parasitol; 2004 Nov; 20(11):524-30. PubMed ID: 15471704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites.
    Lantz CS; Boesiger J; Song CH; Mach N; Kobayashi T; Mulligan RC; Nawa Y; Dranoff G; Galli SJ
    Nature; 1998 Mar; 392(6671):90-3. PubMed ID: 9510253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.